Trials that use: Multiplicity adjustment
New to this method? Read the tutorial →
20,317 results
- Study to Evaluate the Efficacy and Safety of an Every Four Weeks Treatment Regimen of Alirocumab (REGN727/ SAR236553) in Patients With Primary Hypercholesterolemia (ODYSSEY CHOICE 1): Complete Statistical AnalysisIndependent statistical analysis of Study to Evaluate the Efficacy and Safety of an Every Four Weeks Treatment Regimen of Alirocumab (REGN727/ SAR236553) in Patients With Primary Hypercholesterolemia (ODYSSEY CHOICE 1): primary endpoint…
- Study to Evaluate the Efficacy and Safety of APL-2 in Patients With Paroxysmal Nocturnal Hemoglobinuria (PNH): Complete Statistical AnalysisIndependent statistical analysis of Study to Evaluate the Efficacy and Safety of APL-2 in Patients With Paroxysmal Nocturnal Hemoglobinuria (PNH): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Study to Evaluate the Efficacy and Safety of Aripiprazole Administered With Lithium or Valproate Over 12 Weeks in the Treatment of Mania in Bipolar I Disorder: Complete Statistical AnalysisIndependent statistical analysis of Study to Evaluate the Efficacy and Safety of Aripiprazole Administered With Lithium or Valproate Over 12 Weeks in the Treatment of Mania in Bipolar I Disorder: primary endpoint…
- Study to Evaluate the Efficacy and Safety of Benralizumab in Adult Patients With Mild to Moderate Persistent Asthma: Complete Statistical AnalysisIndependent statistical analysis of Study to Evaluate the Efficacy and Safety of Benralizumab in Adult Patients With Mild to Moderate Persistent Asthma: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- Study to Evaluate the Efficacy and Safety of Camidanlumab Tesirine (ADCT-301) in Patients With Relapsed or Refractory Hodgkin Lymphoma: Complete Statistical AnalysisIndependent statistical analysis of Study to Evaluate the Efficacy and Safety of Camidanlumab Tesirine (ADCT-301) in Patients With Relapsed or Refractory Hodgkin Lymphoma: primary endpoint results, effect estimate with confidence interval, sample-size…
- Study to Evaluate the Efficacy and Safety of CC-90001 in Participants With Non-alcoholic Steatohepatitis (NASH) and Liver Fibrosis: Complete Statistical AnalysisIndependent statistical analysis of Study to Evaluate the Efficacy and Safety of CC-90001 in Participants With Non-alcoholic Steatohepatitis (NASH) and Liver Fibrosis: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- Study to Evaluate the Efficacy and Safety of Deferasirox Film-coated Tablet Versus Phlebotomy in Patients With Hereditary Hemochromatosis (HH): Complete Statistical AnalysisIndependent statistical analysis of Study to Evaluate the Efficacy and Safety of Deferasirox Film-coated Tablet Versus Phlebotomy in Patients With Hereditary Hemochromatosis (HH): primary endpoint results, effect estimate with confidence interval, sample-size…
- Study to Evaluate the Efficacy and Safety of Erenumab (AMG 334) in Migraine Prevention: Complete Statistical AnalysisIndependent statistical analysis of Study to Evaluate the Efficacy and Safety of Erenumab (AMG 334) in Migraine Prevention: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Study to Evaluate the Efficacy and Safety of Eribulin Mesylate Administered Biweekly (Q2W) for Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Negative Metastatic Breast Cancer: Complete Statistical AnalysisIndependent statistical analysis of Study to Evaluate the Efficacy and Safety of Eribulin Mesylate Administered Biweekly (Q2W) for Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Negative Metastatic Breast Cancer: primary endpoint…
- Study to Evaluate the Efficacy and Safety of FX006 in Patients With Hip Osteoarthritis: Complete Statistical AnalysisIndependent statistical analysis of Study to Evaluate the Efficacy and Safety of FX006 in Patients With Hip Osteoarthritis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Study to Evaluate the Efficacy and Safety of GSK239512 in Schizophrenia: Complete Statistical AnalysisIndependent statistical analysis of Study to Evaluate the Efficacy and Safety of GSK239512 in Schizophrenia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Study to Evaluate the Efficacy and Safety of Hyoscine Butylbromide Tablets for the Treatment of Occasional or Recurrent Episodes of Gastric or Intestinal Spasm-like Pain or Discomfort: Complete Statistical AnalysisIndependent statistical analysis of Study to Evaluate the Efficacy and Safety of Hyoscine Butylbromide Tablets for the Treatment of Occasional or Recurrent Episodes of Gastric or Intestinal Spasm-like Pain or Discomfort: primary…
- Study to Evaluate the Efficacy and Safety of Leronlimab for Mild to Moderate COVID-19: Complete Statistical AnalysisIndependent statistical analysis of Study to Evaluate the Efficacy and Safety of Leronlimab for Mild to Moderate COVID-19: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Study to Evaluate the Efficacy and Safety of PT20 in Subjects With Hyperphosphataemia and Dialysis Dependent Chronic Kidney Disease: Complete Statistical AnalysisIndependent statistical analysis of Study to Evaluate the Efficacy and Safety of PT20 in Subjects With Hyperphosphataemia and Dialysis Dependent Chronic Kidney Disease: primary endpoint results, effect estimate with confidence interval, sample-size…
- Study to Evaluate the Efficacy and Safety of RZ402 in Diabetic Macular Edema (DME): Complete Statistical AnalysisIndependent statistical analysis of Study to Evaluate the Efficacy and Safety of RZ402 in Diabetic Macular Edema (DME): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Study to Evaluate the Efficacy and Safety of Suptavumab (REGN2222) for the Prevention of Medically Attended RSV (Respiratory Syncytial Virus) Infection in Preterm Infants: Complete Statistical AnalysisIndependent statistical analysis of Study to Evaluate the Efficacy and Safety of Suptavumab (REGN2222) for the Prevention of Medically Attended RSV (Respiratory Syncytial Virus) Infection in Preterm Infants: primary endpoint results, effect…
- Study to Evaluate the Efficacy and Safety of Tamsulosin in Children With Neurogenic Bladder: Complete Statistical AnalysisIndependent statistical analysis of Study to Evaluate the Efficacy and Safety of Tamsulosin in Children With Neurogenic Bladder: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Study to Evaluate the Efficacy and Safety of Treatment With Bendamustine in Combination With Ofatumumab in Previously Untreated Patients With Indolent B-Cell Non-Hodgkin’s Lymphoma (NHL): Complete Statistical AnalysisIndependent statistical analysis of Study to Evaluate the Efficacy and Safety of Treatment With Bendamustine in Combination With Ofatumumab in Previously Untreated Patients With Indolent B-Cell Non-Hodgkin's Lymphoma (NHL): primary endpoint results,…
- Study to Evaluate the Efficacy and Safety of Vibegron Administered Orally for 12 Weeks to Women With Irritable Bowel Syndrome: Complete Statistical AnalysisIndependent statistical analysis of Study to Evaluate the Efficacy and Safety of Vibegron Administered Orally for 12 Weeks to Women With Irritable Bowel Syndrome: primary endpoint results, effect estimate with confidence interval,…
- Study to Evaluate the Efficacy and Tolerability of Debio 1562 in Combination With Rituximab in Participants With Relapsed and/or Refractory DLBCL and Other Forms of NHL: Complete Statistical AnalysisIndependent statistical analysis of Study to Evaluate the Efficacy and Tolerability of Debio 1562 in Combination With Rituximab in Participants With Relapsed and/or Refractory DLBCL and Other Forms of NHL: primary endpoint…
- Study to Evaluate the Efficacy of Androxal in Controlling Blood Glucose in Men With Type-2 Diabetes Mellitus: Complete Statistical AnalysisIndependent statistical analysis of Study to Evaluate the Efficacy of Androxal in Controlling Blood Glucose in Men With Type-2 Diabetes Mellitus: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Study to Evaluate the Efficacy of Etanercept Treatment in Adults Who Failed Therapy With Apremilast: Complete Statistical AnalysisIndependent statistical analysis of Study to Evaluate the Efficacy of Etanercept Treatment in Adults Who Failed Therapy With Apremilast: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Study to Evaluate the Efficacy of the Human Papillomavirus Vaccine in Healthy Adult Women of 26 Years of Age and Older: Complete Statistical AnalysisIndependent statistical analysis of Study to Evaluate the Efficacy of the Human Papillomavirus Vaccine in Healthy Adult Women of 26 Years of Age and Older: primary endpoint results, effect estimate with confidence…
- Study To Evaluate The Efficacy Of Tofacitinib In Patients With SJS/TEN: Complete Statistical AnalysisIndependent statistical analysis of Study To Evaluate The Efficacy Of Tofacitinib In Patients With SJS/TEN: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Study to Evaluate the Efficacy, Safety and Immunogenicity of Influenza Vaccine in Healthy Subjects (Aged 6 to <72 Months) Versus Control Vaccines: Complete Statistical AnalysisIndependent statistical analysis of Study to Evaluate the Efficacy, Safety and Immunogenicity of Influenza Vaccine in Healthy Subjects (Aged 6 to
- Study to Evaluate the Efficacy, Safety and Pharmacokinetics of PT001, PT003, and PT005 Following Chronic Dosing (7 Days) in Patients With Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD): Complete Statistical AnalysisIndependent statistical analysis of Study to Evaluate the Efficacy, Safety and Pharmacokinetics of PT001, PT003, and PT005 Following Chronic Dosing (7 Days) in Patients With Moderate to Very Severe Chronic Obstructive Pulmonary…
- Study to Evaluate the Efficacy, Safety and Tolerability of an Oral Aripiprazole/Escitalopram Combination Therapy in Participants With Major Depressive Disorder (MDD): Complete Statistical AnalysisIndependent statistical analysis of Study to Evaluate the Efficacy, Safety and Tolerability of an Oral Aripiprazole/Escitalopram Combination Therapy in Participants With Major Depressive Disorder (MDD): primary endpoint results, effect estimate with confidence…
- Study to Evaluate the Efficacy, Safety and Tolerability of Bupropion Hydrochloride Extended-release Tablet, and Escitalopram Oxalate Capsule in Subjects With Major Depressive Disorder: Complete Statistical AnalysisIndependent statistical analysis of Study to Evaluate the Efficacy, Safety and Tolerability of Bupropion Hydrochloride Extended-release Tablet, and Escitalopram Oxalate Capsule in Subjects With Major Depressive Disorder: primary endpoint results, effect estimate…
- Study to Evaluate the Efficacy, Safety and Tolerability of Vibegron in Men With Overactive Bladder (OAB) Symptoms on Pharmacological Therapy for Benign Prostatic Hyperplasia (BPH): Complete Statistical AnalysisIndependent statistical analysis of Study to Evaluate the Efficacy, Safety and Tolerability of Vibegron in Men With Overactive Bladder (OAB) Symptoms on Pharmacological Therapy for Benign Prostatic Hyperplasia (BPH): primary endpoint results,…
- Study to Evaluate the Efficacy, Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Sapablursen (Formerly ISIS 702843, IONIS-TMPRSS6-LRx): Complete Statistical AnalysisIndependent statistical analysis of Study to Evaluate the Efficacy, Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Sapablursen (Formerly ISIS 702843, IONIS-TMPRSS6-LRx): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Study to Evaluate the Efficacy, Tolerability and Safety of Octanorm in Patients With Primary Immunodeficiency Diseases: Complete Statistical AnalysisIndependent statistical analysis of Study to Evaluate the Efficacy, Tolerability and Safety of Octanorm in Patients With Primary Immunodeficiency Diseases: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Study to Evaluate the Equivalence of Estradiol Vaginal Cream to Reference Standard in the Treatment of Vaginal Atrophy: Complete Statistical AnalysisIndependent statistical analysis of Study to Evaluate the Equivalence of Estradiol Vaginal Cream to Reference Standard in the Treatment of Vaginal Atrophy: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- Study to Evaluate the Immune Response After a Booster Dose of a Quadrivalent Meningococcal (MenACYW) Conjugate Vaccine When Administered Alone or Concomitantly With a Licensed Meningococcal Serogroup B Vaccine, in Participants Who Received Primary Quadrivalent Meningococcal Conjugate Vaccine (MCV4): Complete Statistical AnalysisIndependent statistical analysis of Study to Evaluate the Immune Response After a Booster Dose of a Quadrivalent Meningococcal (MenACYW) Conjugate Vaccine When Administered Alone or Concomitantly With a Licensed Meningococcal Serogroup B…
- Study to Evaluate the Immunogenicity and Safety of ‘IL-YANG Quadrivalent Influenza Vaccine Inj.’: Complete Statistical AnalysisIndependent statistical analysis of Study to Evaluate the Immunogenicity and Safety of 'IL-YANG Quadrivalent Influenza Vaccine Inj.': primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Study to Evaluate the Immunogenicity and Safety of a Second Vaccination With the Adjuvanted Influenza Vaccine Candidate: Complete Statistical AnalysisIndependent statistical analysis of Study to Evaluate the Immunogenicity and Safety of a Second Vaccination With the Adjuvanted Influenza Vaccine Candidate: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Study to Evaluate the Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals’ Herpes Zoster Vaccine GSK1437173A When Co-administered With GSK Biologicals’ Seasonal Influenza Vaccine GSK2321138A in Adults Aged 50 Years and Older: Complete Statistical AnalysisIndependent statistical analysis of Study to Evaluate the Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals' Herpes Zoster Vaccine GSK1437173A When Co-administered With GSK Biologicals' Seasonal Influenza Vaccine GSK2321138A in Adults Aged 50…
- Study to Evaluate the Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals’ Quadrivalent Influenza Vaccine (GSK2282512A) Compared to Fluzone® Quadrivalent in Children 6 to 35 Months of Age: Complete Statistical AnalysisIndependent statistical analysis of Study to Evaluate the Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals' Quadrivalent Influenza Vaccine (GSK2282512A) Compared to Fluzone® Quadrivalent in Children 6 to 35 Months of Age: primary…
- Study To Evaluate The Impact Of Early Initiation Of Biological Treatment With Ankylosing Spondylitis: Complete Statistical AnalysisIndependent statistical analysis of Study To Evaluate The Impact Of Early Initiation Of Biological Treatment With Ankylosing Spondylitis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Study to Evaluate the Interaction Potential of Clarithromycin XL on Diltiazem Hydrochloride Cream 2% in Healthy Subjects: Complete Statistical AnalysisIndependent statistical analysis of Study to Evaluate the Interaction Potential of Clarithromycin XL on Diltiazem Hydrochloride Cream 2% in Healthy Subjects: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Study to Evaluate the Iovera° Device for Temporary Relief From Knee Pain: Complete Statistical AnalysisIndependent statistical analysis of Study to Evaluate the Iovera° Device for Temporary Relief From Knee Pain: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Study to Evaluate the Long-Term Safety of Hydrocodone Bitartrate Extended-Release Tablets (CEP-33237) in Patients Who Require Opioid Treatment for an Extended Period of Time: Complete Statistical AnalysisIndependent statistical analysis of Study to Evaluate the Long-Term Safety of Hydrocodone Bitartrate Extended-Release Tablets (CEP-33237) in Patients Who Require Opioid Treatment for an Extended Period of Time: primary endpoint results, effect…
- Study to Evaluate the OrthoCor Active System for Pain Relief: Complete Statistical AnalysisIndependent statistical analysis of Study to Evaluate the OrthoCor Active System for Pain Relief: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05244187).
- Study to Evaluate the Pharmacokinetics and Pharmacodynamics of Dabigatran Etexilate in Patients With Stable Severe Renal Disease.: Complete Statistical AnalysisIndependent statistical analysis of Study to Evaluate the Pharmacokinetics and Pharmacodynamics of Dabigatran Etexilate in Patients With Stable Severe Renal Disease.: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Study to Evaluate the Pharmacokinetics of Mucinex 600 mg Extended-release Bi-layer Tablet in Healthy Volunteers: Complete Statistical AnalysisIndependent statistical analysis of Study to Evaluate the Pharmacokinetics of Mucinex 600 mg Extended-release Bi-layer Tablet in Healthy Volunteers: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Study to Evaluate the Pharmacokinetics of Tenofovir Alafenamide (TAF) in Adults With Normal Hepatic Function and Adults With Severe Hepatic Impairment: Complete Statistical AnalysisIndependent statistical analysis of Study to Evaluate the Pharmacokinetics of Tenofovir Alafenamide (TAF) in Adults With Normal Hepatic Function and Adults With Severe Hepatic Impairment: primary endpoint results, effect estimate with confidence…
- Study to Evaluate the Pharmacokinetics of Velpatasvir in Participants With Normal Renal Function and Severe Renal Impairment: Complete Statistical AnalysisIndependent statistical analysis of Study to Evaluate the Pharmacokinetics of Velpatasvir in Participants With Normal Renal Function and Severe Renal Impairment: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Study to Evaluate the Pharmacokinetics, Safety, and Antiviral Activity of the Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide (E/C/F/TAF) Single Tablet Regimen (STR) in HIV-1 Infected Antiretroviral Treatment-Naive Adolescents and Virologically Suppressed Children: Complete Statistical AnalysisIndependent statistical analysis of Study to Evaluate the Pharmacokinetics, Safety, and Antiviral Activity of the Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide (E/C/F/TAF) Single Tablet Regimen (STR) in HIV-1 Infected Antiretroviral Treatment-Naive Adolescents and Virologically Suppressed Children:…
- Study To Evaluate The Response To Enbrel And The Impact Of Rheumatoid Factor(RF) And Anti-Cyclic Citrullinated Peptide(Anti-CCP) In Rheumatoid Arthritis(RA) Patients: Complete Statistical AnalysisIndependent statistical analysis of Study To Evaluate The Response To Enbrel And The Impact Of Rheumatoid Factor(RF) And Anti-Cyclic Citrullinated Peptide(Anti-CCP) In Rheumatoid Arthritis(RA) Patients: primary endpoint results, effect estimate with confidence…
- Study to Evaluate the Safety and Activity of BB3 to Treat Heart Attack: Complete Statistical AnalysisIndependent statistical analysis of Study to Evaluate the Safety and Activity of BB3 to Treat Heart Attack: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Study to Evaluate the Safety and Antiviral Activity of Remdesivir (GS-5734™) in Participants With Severe Coronavirus Disease (COVID-19): Complete Statistical AnalysisIndependent statistical analysis of Study to Evaluate the Safety and Antiviral Activity of Remdesivir (GS-5734™) in Participants With Severe Coronavirus Disease (COVID-19): primary endpoint results, effect estimate with confidence interval, sample-size planning…